EA201391206A1 - Способы синтеза производных предшественника молибдоптерина z - Google Patents
Способы синтеза производных предшественника молибдоптерина zInfo
- Publication number
- EA201391206A1 EA201391206A1 EA201391206A EA201391206A EA201391206A1 EA 201391206 A1 EA201391206 A1 EA 201391206A1 EA 201391206 A EA201391206 A EA 201391206A EA 201391206 A EA201391206 A EA 201391206A EA 201391206 A1 EA201391206 A1 EA 201391206A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- formula
- methods
- precondent
- molybdopterin
- derivatives
- Prior art date
Links
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 108010046778 molybdenum cofactor Proteins 0.000 title 1
- HPEUEJRPDGMIMY-IFQPEPLCSA-N molybdopterin Chemical compound O([C@H]1N2)[C@H](COP(O)(O)=O)C(S)=C(S)[C@@H]1NC1=C2N=C(N)NC1=O HPEUEJRPDGMIMY-IFQPEPLCSA-N 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 238000010189 synthetic method Methods 0.000 abstract 2
- -1 derivatives Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 208000001488 molybdenum cofactor deficiency Diseases 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
- C07F9/6574—Esters of oxyacids of phosphorus
- C07F9/65744—Esters of oxyacids of phosphorus condensed with carbocyclic or heterocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
- C07D491/147—Ortho-condensed systems the condensed system containing one ring with oxygen as ring hetero atom and two rings with nitrogen as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Saccharide Compounds (AREA)
Abstract
В настоящем изобретении предлагаются способы синтеза для получения соединения формулы (I). Также в настоящем изобретении предлагаются способы синтеза для получения соединения формулы (XIII). Изобретение также относится к полезным промежуточным соединениям, производным, пролекарствам и фармацевтически приемлемым солям, сольватам и гидратам соединений формулы (I) и формулы (XIII). Такие соединения применимы для лечения заболеваний, ассоциированных с недостаточностью молибденового кофактора.
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161444389P | 2011-02-18 | 2011-02-18 | |
US201161444280P | 2011-02-18 | 2011-02-18 | |
US201161444399P | 2011-02-18 | 2011-02-18 | |
US201161498808P | 2011-06-20 | 2011-06-20 | |
US201161498801P | 2011-06-20 | 2011-06-20 | |
US201261599314P | 2012-02-15 | 2012-02-15 | |
PCT/US2012/025689 WO2012112922A1 (en) | 2011-02-18 | 2012-02-17 | Methods for synthesizing molybdopterin precursor z derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201391206A1 true EA201391206A1 (ru) | 2014-02-28 |
Family
ID=46672966
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201391206A EA201391206A1 (ru) | 2011-02-18 | 2012-02-17 | Способы синтеза производных предшественника молибдоптерина z |
Country Status (16)
Country | Link |
---|---|
US (2) | US9260462B2 (ru) |
EP (1) | EP2675278B1 (ru) |
JP (1) | JP5972911B2 (ru) |
KR (1) | KR20140007431A (ru) |
AR (1) | AR085291A1 (ru) |
AU (1) | AU2012219292B2 (ru) |
BR (1) | BR112013020864A2 (ru) |
CA (1) | CA2827679C (ru) |
CO (1) | CO7071121A2 (ru) |
EA (1) | EA201391206A1 (ru) |
ES (1) | ES2569252T3 (ru) |
IL (1) | IL227917A0 (ru) |
MX (1) | MX2013009501A (ru) |
SG (1) | SG192826A1 (ru) |
TW (1) | TW201241005A (ru) |
WO (1) | WO2012112922A1 (ru) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9260462B2 (en) | 2011-02-18 | 2016-02-16 | Alexion Pharmaceuticals, Inc. | Methods for synthesizing molybdopterin precursor Z derivatives |
US20180008620A1 (en) * | 2015-01-15 | 2018-01-11 | Mayo Foundation For Medical Education And Research | Methods of treating neurological inflammatory disorders |
WO2017019532A1 (en) | 2015-07-24 | 2017-02-02 | Alexion Pharmaceuticals, Inc. | Precursor z (cpmp) to treat molybdenum cofactor deficiency type a |
AU2016378723B2 (en) | 2015-12-22 | 2021-09-30 | SHY Therapeutics LLC | Compounds for the treatment of cancer and inflammatory disease |
JP7514005B2 (ja) | 2017-06-21 | 2024-07-10 | シャイ・セラピューティクス・エルエルシー | がん、炎症性疾患、ラソパシー、及び線維性疾患の治療のためのrasスーパーファミリーと相互作用する化合物 |
WO2023227763A1 (en) | 2022-05-27 | 2023-11-30 | Arlanxeo Deutschland Gmbh | Rubber compounds of functionalized conjugated diene rubbers and silica fillers |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
US4713454A (en) | 1985-01-28 | 1987-12-15 | Shiratori Pharmaceutical Co., Ltd. | Preparation process of (6R)-tetrahydro-L-biopterin |
EP1218512A2 (en) * | 1999-06-18 | 2002-07-03 | Elitra Pharmaceuticals, Inc. | Nucleotide sequences of moraxella catarrhalis genome |
CA2413330A1 (en) | 2000-06-28 | 2002-01-03 | Smithkline Beecham P.L.C. | Wet milling process |
US20030207430A1 (en) * | 2001-03-01 | 2003-11-06 | Tang Y. Tom | Human enzyme molecules |
DE102004004642A1 (de) * | 2004-01-29 | 2006-04-27 | Schwarz, Guenter, Dr. | Produktion, Gewinnung und therapeutischer Einsatz des Molybdopterin-Derivats Precursor Z zur Therapie der Stoffwechselerkrankung humaner Molybdäncofaktor-Defizienz und anderer assoziierter Krankheiten |
WO2007052308A2 (en) | 2005-11-03 | 2007-05-10 | Brain N' Beyond Biotech Pvt. Ltd. | Glyco-phosphorylated biologically active agents |
AU2008206486C1 (en) | 2007-01-12 | 2013-09-26 | Biomarin Pharmaceutical Inc. | Tetrahydrobiopterin prodrugs |
US7888506B2 (en) * | 2007-01-26 | 2011-02-15 | Duquesne University Of The Holy Spirit | Composition, synthesis, and use of a new class of fluorophores |
CN101959891A (zh) | 2008-01-07 | 2011-01-26 | 生物马林药物股份有限公司 | 合成四氢生物蝶呤的方法 |
CA2715781C (en) * | 2008-02-26 | 2016-06-28 | Sandoz Ag | Preparation of morpholine derivatives |
US9260462B2 (en) | 2011-02-18 | 2016-02-16 | Alexion Pharmaceuticals, Inc. | Methods for synthesizing molybdopterin precursor Z derivatives |
-
2012
- 2012-02-17 US US14/000,055 patent/US9260462B2/en active Active
- 2012-02-17 CA CA2827679A patent/CA2827679C/en active Active
- 2012-02-17 EA EA201391206A patent/EA201391206A1/ru unknown
- 2012-02-17 KR KR1020137023985A patent/KR20140007431A/ko not_active Application Discontinuation
- 2012-02-17 SG SG2013062591A patent/SG192826A1/en unknown
- 2012-02-17 AR ARP120100560A patent/AR085291A1/es unknown
- 2012-02-17 AU AU2012219292A patent/AU2012219292B2/en not_active Ceased
- 2012-02-17 JP JP2013554645A patent/JP5972911B2/ja not_active Expired - Fee Related
- 2012-02-17 ES ES12747519.2T patent/ES2569252T3/es active Active
- 2012-02-17 EP EP12747519.2A patent/EP2675278B1/en active Active
- 2012-02-17 TW TW101105390A patent/TW201241005A/zh unknown
- 2012-02-17 BR BR112013020864A patent/BR112013020864A2/pt not_active IP Right Cessation
- 2012-02-17 MX MX2013009501A patent/MX2013009501A/es not_active Application Discontinuation
- 2012-02-17 WO PCT/US2012/025689 patent/WO2012112922A1/en active Application Filing
-
2013
- 2013-08-11 IL IL227917A patent/IL227917A0/en unknown
- 2013-08-22 CO CO13199113A patent/CO7071121A2/es unknown
-
2014
- 2014-03-07 US US14/200,676 patent/US20140303367A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20140303367A1 (en) | 2014-10-09 |
ES2569252T3 (es) | 2016-05-09 |
US9260462B2 (en) | 2016-02-16 |
KR20140007431A (ko) | 2014-01-17 |
WO2012112922A1 (en) | 2012-08-23 |
CA2827679C (en) | 2020-06-02 |
JP2014510054A (ja) | 2014-04-24 |
CO7071121A2 (es) | 2014-09-30 |
US20140323726A1 (en) | 2014-10-30 |
AU2012219292B2 (en) | 2015-03-05 |
TW201241005A (en) | 2012-10-16 |
AU2012219292A1 (en) | 2013-03-14 |
EP2675278A4 (en) | 2014-08-20 |
SG192826A1 (en) | 2013-09-30 |
AR085291A1 (es) | 2013-09-18 |
IL227917A0 (en) | 2013-09-30 |
BR112013020864A2 (pt) | 2019-09-24 |
JP5972911B2 (ja) | 2016-08-17 |
NZ614009A (en) | 2014-08-29 |
EP2675278B1 (en) | 2016-02-17 |
CA2827679A1 (en) | 2012-08-23 |
EP2675278A1 (en) | 2013-12-25 |
MX2013009501A (es) | 2014-02-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1119731T1 (el) | Διαδικασια για την παρασκευη παραγωγων χολικου οξεος | |
CY1119422T1 (el) | Παραγωγα μπετουλινης | |
CY1118004T1 (el) | Αναστολεις cdk | |
UY33227A (es) | Compuestos de pirrolopirimidina como inhibidores de la cdk4/6 | |
CY1118093T1 (el) | Φαρμακοτεχνικες μορφες που περιλαμβανουν παραγωγα 1-(bhta-d-γλυκοπυρανοζυλ)-2-θειενυλμεθυλβενζολιου ως αναστολεις sglt | |
EA201201378A1 (ru) | Определенные аминопиримидины, композиции на их основе и способы их использования | |
EA201201377A1 (ru) | Определенные аминопиридазины, композиции на их основе и способы их использования | |
AU2012313888A8 (en) | 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH | |
UA111626C2 (uk) | Похідні дигідрохінолін-2-ону | |
UA108926C2 (ru) | LibreOffice? [2,3-D] +" +" !+ | |
MD20180040A2 (ru) | Ингибиторы вируса гепатита С | |
EA201290632A1 (ru) | Производные бетулина | |
CU24039B1 (es) | Derivados de imidazolidin-2-ona 1,3-disustituida como inhibidores de cyp17 | |
UY34825A (es) | Síntesis de compuestos heterocíclicos | |
EA201291414A1 (ru) | Имидазопиридиновые производные, способ их получения и терапевтическое использование | |
EA201490474A1 (ru) | Аминохиназолины в качестве ингибиторов киназ | |
EA201590979A1 (ru) | Способы и промежуточные химические соединения для получения фармацевтических средств | |
MY164776A (en) | Heterocyclic compound | |
UY33226A (es) | Compuestos de pirrolopirimidina deuterada como inhibidores de la cdk4/6 | |
MX338551B (es) | Nuevos compuestos de piridina fusionada como inhibidores de caseina quinasa. | |
EA201491149A1 (ru) | Пиразолопиридиновые производные, способы их получения и их терапевтическое применение | |
EA201590319A1 (ru) | Новые бициклические пиридиноны | |
EA201391206A1 (ru) | Способы синтеза производных предшественника молибдоптерина z | |
EA201190293A1 (ru) | Пролекарства триптолида | |
EA201490754A1 (ru) | Производные карбамата/мочевины, содержащие пиперидиновые и пиперазиновые кольца, в качестве ингибиторов н3 рецептора |